Puma Biotechnology, Inc.
Income Statement
| Line Item | Jun 2018 | Mar 2018 | Dec 2017 | Sep 2017 |
|---|---|---|---|---|
| Revenue | $50.8M | $66.5M | $21.6M | $6.1M |
| Cost of Revenue | $8.8M | $6.4M | — | $1.5M |
| Gross Profit | $41.9M | $60.1M | — | $4.6M |
| Gross Margin | 82.6% | 90.4% | — | 74.9% |
| Operating Expenses | ||||
| Research & Development | $43.2M | $46.9M | $50.3M | $49.5M |
| SG&A Expense | $40.1M | $36.6M | $30.9M | $32.5M |
| Operating Income | $-41.4M | $-23.4M | $-63.6M | $-77.4M |
| Operating Margin | -81.6% | -35.2% | -294.2% | -1,274.3% |
| Interest Expense | $2.6M | $1.1M | — | — |
| Pretax Income | — | — | — | — |
| Income Tax Expense | — | — | — | — |
| Net Income | $-44.3M | $-24.3M | $-64.1M | $-77.2M |
| Net Margin | -87.3% | -36.6% | -296.5% | -1,270.0% |
| EPS (Basic) | $-1.17 | $-0.65 | $-1.71 | $-2.07 |
| EPS (Diluted) | $-1.17 | $-0.65 | $-1.71 | $-2.07 |
| Shares Outstanding (Basic) | 37.9M | 37.8M | 37.6M | 37.4M |
| Shares Outstanding (Diluted) | 37.9M | 37.8M | 37.6M | 37.4M |
| Dividends Per Share | — | — | — | — |